Literature DB >> 11481455

Brain glucose utilization in mice with a targeted mutation in the thyroid hormone alpha or beta receptor gene.

Y Itoh1, T Esaki, M Kaneshige, H Suzuki, M Cook, L Sokoloff, S Y Cheng, J Nunez.   

Abstract

Brain glucose utilization is markedly depressed in adult rats made cretinous after birth. To ascertain which subtype of thyroid hormone (TH) receptors, TRalpha1 or TRbeta, is involved in the regulation of glucose utilization during brain development, we used the 2-[(14)C]deoxyglucose method in mice with a mutation in either their TRalpha or TRbeta gene. A C insertion produced a frameshift mutation in their carboxyl terminus. These mutants lacked TH binding and transactivation activities and exhibited potent dominant negative activity. Glucose utilization in the homozygous TRbetaPV mutant mice and their wild-type siblings was almost identical in 19 brain regions, whereas it was markedly reduced in all brain regions of the heterozygous TRalpha1PV mice. These suggest that the alpha1 receptor mediates the TH effects in brain. Inasmuch as local cerebral glucose utilization is closely related to local synaptic activity, we also examined which thyroid hormone receptor is involved in the expression of synaptotagmin-related gene 1 (Srg1), a TH-positively regulated gene involved in the formation and function of synapses [Thompson, C. C. (1996) J. Neurosci. 16, 7832-7840]. Northern analysis showed that Srg1 expression was markedly reduced in the cerebellum of TRalpha(PV/+) mice but not TRbeta(PV/PV) mice. These results show that the same receptor, TRalpha1, is involved in the regulation by TH of both glucose utilization and Srg1 expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481455      PMCID: PMC55552          DOI: 10.1073/pnas.171319498

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Structural insights into the molecular mechanism of calcium-dependent vesicle-membrane fusion.

Authors:  A T Brunger
Journal:  Curr Opin Struct Biol       Date:  2001-04       Impact factor: 6.809

Review 2.  Transcriptional repression by nuclear hormone receptors.

Authors:  X Hu; M A Lazar
Journal:  Trends Endocrinol Metab       Date:  2000 Jan-Feb       Impact factor: 12.015

3.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

Review 4.  Thyroid and central nervous development.

Authors:  J T Eayrs
Journal:  Sci Basis Med Annu Rev       Date:  1966

Review 5.  Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose.

Authors:  L Sokoloff
Journal:  J Cereb Blood Flow Metab       Date:  1981       Impact factor: 6.200

6.  Local cerebral glucose utilization in the newborn macaque monkey.

Authors:  C Kennedy; O Sakurada; M Shinohara; M Miyaoka
Journal:  Ann Neurol       Date:  1982-10       Impact factor: 10.422

Review 7.  The mechanism of action of thyroid hormones.

Authors:  J Zhang; M A Lazar
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

8.  Local cerebral glucose metabolism in newborn dogs: effects of hypoxia and halothane anesthesia.

Authors:  T E Duffy; M Cavazzuti; N F Cruz; L Sokoloff
Journal:  Ann Neurol       Date:  1982-03       Impact factor: 10.422

9.  Local cerebral glucose utilization in the adult cretinous rat.

Authors:  D Dow-Edwards; A M Crane; B Rosloff; C Kennedy; L Sokoloff
Journal:  Brain Res       Date:  1986-05-14       Impact factor: 3.252

View more
  25 in total

Review 1.  Physiological consequences of the TRalpha1 aporeceptor state.

Authors:  Jens Mittag; Karin Wallis; Björn Vennström
Journal:  Heart Fail Rev       Date:  2008-11-14       Impact factor: 4.214

2.  Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice.

Authors:  J McKee Alderman; Kevin Flurkey; Natasha L Brooks; Sneha B Naik; Jonathan M Gutierrez; Urmila Srinivas; Kristen B Ziara; Linhong Jing; Gunnar Boysen; Rod Bronson; Simon Klebanov; Xian Chen; James A Swenberg; Mats Stridsberg; Carol E Parker; David E Harrison; Terry P Combs
Journal:  Exp Gerontol       Date:  2008-06-07       Impact factor: 4.032

Review 3.  Multigenic control of thyroid hormone functions in the nervous system.

Authors:  Jacques Nunez; Francesco S Celi; Lily Ng; Douglas Forrest
Journal:  Mol Cell Endocrinol       Date:  2008-03-25       Impact factor: 4.102

Review 4.  Thyroid hormone and cerebellar development.

Authors:  Grant W Anderson
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 5.  Thyroid hormone action in metabolic regulation.

Authors:  Yiyun Song; Xuan Yao; Hao Ying
Journal:  Protein Cell       Date:  2011-05-26       Impact factor: 14.870

Review 6.  Making sense with thyroid hormone--the role of T(3) in auditory development.

Authors:  Lily Ng; Matthew W Kelley; Douglas Forrest
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

Review 7.  Clinical Consequences of Mutations in Thyroid Hormone Receptor-α1.

Authors:  Alies A van Mullem; Theo J Visser; Robin P Peeters
Journal:  Eur Thyroid J       Date:  2014-03-14

8.  Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cells.

Authors:  Fabrice Chatonnet; Romain Guyot; Gérard Benoît; Frederic Flamant
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 9.  Supply and demand in cerebral energy metabolism: the role of nutrient transporters.

Authors:  Ian A Simpson; Anthony Carruthers; Susan J Vannucci
Journal:  J Cereb Blood Flow Metab       Date:  2007-06-20       Impact factor: 6.200

Review 10.  Expression of thyroid hormone receptor isoforms in the oligodendrocyte lineage.

Authors:  Louis L Sarliève; Angeles Rodríguez-Peña; Keith Langley
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.